Literature DB >> 10825563

Monolithic osmotic tablet system for nifedipine delivery.

L Liu1, G Khang, J M Rhee, H B Lee.   

Abstract

The monolithic osmotic tablet system, which is composed of a monolithic tablet coated with cellulose acetate (CA) membrane drilled with two orifices on both side surfaces, has been described. The influences of tablet formulation variables including molecular weight (MW) and amount of polyethylene oxide (PEO), amount of potassium chloride (KCl), and amount of rice starch as well as nifedipine loading have been investigated. The optimal tablet formulation and the osmotic-suspending co-controlled delivery mechanisms have been proposed. Orifice size and membrane variables including nature and amount of plasticizers as well as thickness on drug release have also been studied. The in vitro release profiles of the optimal system have been evaluated in various release media and different agitation rates, and compared with commercialized conventional capsule and push-pull osmotic tablet. It was found that PEO with MW of 300000 g/mol was suitable to be thickening agent, both amount of KCl and amount of PEO had comparable and profoundly positive effects, while nifedipine loading had a strikingly negative influence on drug release. It could be found that the optimal orifice size was in the range of 0.25-1.41 mm. It has also been observed that hydrophilic plasticizer polyethylene glycol (PEG) improved drug release, whereas hydrophobic plasticizer triacetin depressed drug release when they were incorporated in CA membrane. The monolithic osmotic tablet system was found to be able to deliver nifedipine at the rate of approximate zero-order up to 24 h, independent of both environmental media and agitation rate, and substantially comparable with the push-pull osmotic tablet. The monolithic osmotic tablet system was simple to be prepared as exempting from push layer and simplifying in the orifice drilling compared with the push-pull osmotic tablet. The monolithic osmotic tablet system may be used in drug controlled delivery field, especially suitable for water-insoluble drugs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10825563     DOI: 10.1016/s0168-3659(00)00222-4

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  8 in total

1.  Development of push-pull osmotic tablets using chitosan-poly(acrylic acid) interpolymer complex as an osmopolymer.

Authors:  Wichan Ketjinda; Nuttanan Sinchaipanid; Pichet Limsuwan; Hans Leuenberger; Ampol Mitrevej
Journal:  AAPS PharmSciTech       Date:  2010-12-23       Impact factor: 3.246

2.  A novel gastro-retentive osmotic pump capsule using asymmetric membrane technology: in vitro and in vivo evaluation.

Authors:  Jin Guan; Liying Zhou; Yusheng Pan; Haitao Han; Hongtao Xu; Weisan Pan
Journal:  Pharm Res       Date:  2009-10-27       Impact factor: 4.200

3.  Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material.

Authors:  João F Pinto; Kathrin F Wunder; Andrea Okoloekwe
Journal:  AAPS J       Date:  2004       Impact factor: 4.009

4.  Quality by Design (QbD)-Based Numerical and Graphical Optimization Technique for the Development of Osmotic Pump Controlled-Release Metoclopramide HCl Tablets.

Authors:  Sadaf Farooqi; Rabia Ismail Yousuf; Muhammad Harris Shoaib; Kamran Ahmed; Sabah Ansar; Tazeen Husain
Journal:  Drug Des Devel Ther       Date:  2020-11-26       Impact factor: 4.162

5.  Investigation of release pattern of a drug with low solubility through asymmetric membrane capsules.

Authors:  P K Sahoo; Harleen Makar
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

6.  Floating matrix tablets of domperidone formulation and optimization using simplex lattice design.

Authors:  Shailesh Prajapati; Laxmanbhai Patel; Chhaganbhai Patel
Journal:  Iran J Pharm Res       Date:  2011       Impact factor: 1.696

7.  Development and optimization of buspirone oral osmotic pump tablet.

Authors:  K Derakhshandeh; M Ghasemnejad Berenji
Journal:  Res Pharm Sci       Date:  2014 Jul-Aug

8.  Preparation and evaluation of bilayer-core osmotic pump tablets contained topiramate.

Authors:  Wen Lin; Yinke Li; Qiongzhi Shi; Xiangru Liao; Yuan Zeng; Wei Tian; Xiangyang Xie; Hui Liu
Journal:  PLoS One       Date:  2022-02-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.